Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Tamari
    Tamari
  4. Jakubowski
    Jakubowski
  5. Papadopoulos
    Papadopoulos
  6. Gyurkocza
    Gyurkocza
  7. Shah
    Shah
  8. Shaffer
    Shaffer
  9. Devlin
    Devlin
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Bone Marrow Transplant (54)
  2. Center for Hematologic Malignancies (54)
  3. Department of Medicine (54)
  4. Hematologic Malignancies, Division of (54)
  5. Survivorship Research (47)
  6. CTCR Scholars (45)
  7. MSK Grad Students (43)
  8. Master of Science in Clinical and Translational Cancer Research (43)
  9. DigITs Research Group (32)
  10. Biostatistics Service (27)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Brian Shaffer"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (20)
Groups
  1. Bone Marrow Transplant (54)
  2. Center for Hematologic Malignancies (54)
  3. Department of Medicine (54)
  4. Hematologic Malignancies, Division of (54)
  5. Survivorship Research (47)
  6. CTCR Scholars (45)

More Groups

People
  1. Brian Shaffer (54)
  2. Miguel-Angel Perales (46)
  3. Sergio Giralt (46)
  4. Roni Tamari (37)
  5. Ann Jakubowski (35)
  6. Esperanza Papadopoulos (35)

More People

Years
  1. 2023 (1)
  2. 2022 (6)
  3. 2021 (4)
  4. 2020 (11)
  5. 2019 (11)
  6. 2018 (10)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (42)
  2. Transplantation and Cellular Therapy (11)
  3. Best Practice and Research: Clinical Haematology (1)

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a national marrow donor program-sponsored prospective clinical trial
    Journal Article

    Shaw, B. E.; Jimenez-Jimenez, A. M.; Burns, L. J.; Logan, B. R.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M. J; Perales, M. A.; Devlin, S. M.; Brown, S.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Wang, T. P.; Ponce, D. M.; Beitinjaneh, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Analysis of disparities in speed to BMT referral & allograft in 279 adults with AML: Non-Europeans have delayed referrals & cord blood can facilitate prompt transplantation regardless of ancestry
    Meeting Abstract

    Warren, F.; Davis, E.; Scaradavou, A.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Papadopoulos, E. B.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse
    Meeting Abstract

    Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in allograft recipients
    Journal Article

    Tamari, R.; Brown, S.; Devlin, S. M.; Kosuri, S.; Maloy, M. A.; Ponce, D. M.; Sauter, C.; Shaffer, B.; Dahi, P.; Young, J. W.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save